UPDATE: Fastenal (FAST) Misses Q1 EPS by 1c; Gross Margins Compress, Sales Growth Decelerates
Get Alerts FAST Hot Sheet
Price: $46.12 +0.50%
EPS Growth %: +13.8%
Financial Fact:
Loss on sale of property and equipment: -182K
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +13.8%
Financial Fact:
Loss on sale of property and equipment: -182K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
(Updated - April 12, 2012 7:41 AM EDT)
Fastenal Co (Nasdaq: FAST) reported Q1 EPS of $0.34 (basic), $0.01 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $768.9 million versus the consensus estimate of $767.55 million.
UPDATE: Shares are up 1.8 percent early Thursday.
The Company reported sales growth rates of 21.3 percent in January, 20.0 percent in February, and 19.3 percent in March, a decelerating trend.
Gross profit percentage moved from 52.0 percent last year to 51.3 percent in the recent quarter.
Fastenall didn't buyback any stock in the quarter and has buyback ability on 1.8 million shares still outstanding.
For earnings history and earnings-related data on Fastenal Co (FAST) click here.
Fastenal Co (Nasdaq: FAST) reported Q1 EPS of $0.34 (basic), $0.01 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $768.9 million versus the consensus estimate of $767.55 million.
UPDATE: Shares are up 1.8 percent early Thursday.
The Company reported sales growth rates of 21.3 percent in January, 20.0 percent in February, and 19.3 percent in March, a decelerating trend.
Gross profit percentage moved from 52.0 percent last year to 51.3 percent in the recent quarter.
Fastenall didn't buyback any stock in the quarter and has buyback ability on 1.8 million shares still outstanding.
For earnings history and earnings-related data on Fastenal Co (FAST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
- AXT appoints Tracy Liu to its board of directors
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share